Robert J. Sommer, MD

Expertise in: 
Cardiovascular Disease
Board Certifications: 
Pediatric Cardiology, Pediatrics
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Cardiovascular Disease, Valvular Heart Disease, Adult Congenital Heart Disease (ACHD), Complex Congenital Heart Disease, Pediatric Congenital Heart Disease, Congenital Abnormalities, Atrial Septal Defect, Tetralogy of Fallot, Patent Ductus Arteriosus, Ventricular Septal Defect, Transcatheter Atrial Septal Defect, Valve Replacement, Atrial Fibrillation, Structural Heart Disease

Academic Appointments

  • Associate Professor of Medicine at CUMC

Administrative Titles

  • Director, Invasive Adult Congenital Heart Disease

SOMMER PFO STROKE FINAL

Dr. Bob Sommer trained in Pediatrics and Pediatric Cardiology, and started the first Pediatric Interventional Catheterization Laboratory in New York City in 1991, and has been Board Certified in Pediatric Cardiology since 1991. In 1999, Dr. Sommer redirected his focus to the adult patient with Congenital Heart Disease, first by starting his own practice to care for this underserved population, then joining the faculty of Columbia University Medical Center in 2005. In 2017, Dr. Sommer was Board Certified in the new ABIM sub-specialty of Adult Congenital Heart Disease.

Dr. Sommer performs catheter intervention for a wide array of congenital and structural disease, in “babies” of all ages including over 200 atrial septal defect, ventricular septal defect and patent foramen ovale (PFO) closures annually.

Dr. Sommer was an investigator in the CLOSURE I, RESPECT and REDUCE PFO/Stroke Trials, and was the National Cardiology PI for the ESCAPE Migraine-PFO trial. He was the Co-National PI on the ASSURED Trial which led to the recent FDA approval of the Cardioform ASD Occluder. He will be the National Cardiology PI on the upcoming RELIEF Migraine-PFO Trial, based on groundbreaking research done with NP Barbara Robbins. Two manuscripts on this topic were published in the journal NEUROLOGY in November 2018. 

Dr. Sommer directs the Left Atrial Appendage Closure Team at Columbia, having participated in the PREVAIL Trial and the CAP2 registry using the Watchman device. He is an investigator in the Amulet and Conformal LAA device trials. He is the local PI for the COMPASSION S3 Trial, using the Edwards Sapien 3 valve in the pulmonary position. 

Dr. Sommer and Ms. Robbins are the primary cardiac caretakers for over 300 pediatric and adult patients with congenital heart disease, with more than 1500 office visits each year. 

Dr. Sommer is an Associate Professor of Medicine at Columbia University Irving Medical Center.

Hospital Affiliations

  • NewYork-Presbyterian/Lawrence Hospital
  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-342-0886

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary
White Plains, NY - 15 North Broadway Office
15 North Broadway
White Plains, NY 10601
NewYork-Presbyterian/Lawrence Hospital
55 Palmer Avenue
Bronxville, NY 10708

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Horizon Blue Cross Blue Shield

  • Horizon Blue Cross Blue Shield

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO
  • The Empire Plan (NYSHIP)

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • New York University School of Medicine
  • Residency: Mount Sinai Hospital
  • Fellowship: Mount Sinai Hospital
  • Fellowship: Boston Children's Hospital

Board Certifications

  • Pediatric Cardiology
  • Pediatrics

Honors & Awards

Best Doctors in New York (Castle Connelly – NY Magazine) 2001-4, 2006-8, 2011
Best Doctors New York Metro Area (Castle Connelly)  2005-16
Best Doctors in America (Castle Connelly)   2006-16
Patients’ Choice Award (Castle Connelly)   2010-16
Compassionate Doctor Award (Castle Connelly)   2013-15
Rotary Club/Gift of Life – Humanitarian Award   2008
SCARC Guardianship Services – Distinguished Services Award for Exceptional and Compassionate Care  2008
New York Family Magazine – Top Pediatrician   2008

America's Top Doctor
NY Top Doctor

Research

Grants

THE CONFORMAL EARLY FEASIBILITY STUDY AN EVALUATION OF THE SAFETY AND PERFORMANCE OF THE CONFORMAL LEFT ATRIAL APPENDAGE SEAL FOR LEFT ATRIAL APPENDAGE OCCLUSION (P&S Industry Clinical Trial)

Jan 8 2019 - Jan 8 2024

AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER RANDOMIZED CONTROLLED TRIAL (P&S Industry Clinical Trial)

Jul 6 2017 - Jul 6 2022

GORE? CARDIOFORM ASD OCCLUDER CLINICAL STUDY: A STUDY TO EVALUATE SAFETY AND EFFICACY IN THE TREATMENT OF TRANSCATHETER CLOSURE OF OSTIUM SECUNDUM ATRIAL SEPTAL DEFECTS (ASDS) (P&S Industry Clinical Trial)

May 16 2017 - May 16 2022

FDS-0005 CONTROLLED, WITHIN SUBJECT COMPARISON OF CARDIOX FDS TECHNOLOGY TO TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) AND CARDIOX FDS TECHNOLOGY TO TRANSCRANIAL DOPPLER (TCD) FOR THE DETECTION OF RIGHT-TO-LEFT SHUNTS (P&S Industry Clinical Trial)

Mar 13 2013 - Mar 13 2018

PIVOTAL-CARDIOX (P&S Industry Clinical Trial)

Oct 28 2011 - Oct 28 2016

PREVAIL (P&S Industry Clinical Trial)

Aug 8 2011 - Aug 18 2016

HYPOXEMIA TRIAL: A TWO CENTER, OPEN LABEL, FEASIBILITY STUDY TO ASSESS THE IMPACT OF PATENT FORAMEN OVALE CLOSURE (P&S Industry Clinical Trial)

Mar 12 2010 - Mar 12 2015

CARDIOX STUDY: CARDIOX SHUNT DETECTION TECHNOLOGY FEASIBILITY (P&S Industry Clinical Trial)

Aug 27 2009 - Aug 27 2014